- Home
- MNDR vs PPBT Comparison
MNDR vs PPBT Comparison
Compare MNDR & PPBT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MNDR
- PPBT
- Stock Information
- Founded
- MNDR 2016
- PPBT 2010
- Country
- MNDR Singapore
- PPBT Israel
- Employees
- MNDR N/A
- PPBT N/A
- Industry
- MNDR
- PPBT Biotechnology: Pharmaceutical Preparations
- Sector
- MNDR
- PPBT Health Care
- Exchange
- MNDR Nasdaq
- PPBT Nasdaq
- Market Cap
- MNDR 10.1M
- PPBT 8.7M
- IPO Year
- MNDR 2024
- PPBT N/A
- Fundamental
- Price
- MNDR $0.28
- PPBT $3.13
- Analyst Decision
- MNDR
- PPBT Strong Buy
- Analyst Count
- MNDR 0
- PPBT 2
- Target Price
- MNDR N/A
- PPBT $126.50
- AVG Volume (30 Days)
- MNDR 1.7M
- PPBT 46.6K
- Earning Date
- MNDR 10-29-2024
- PPBT 03-04-2025
- Dividend Yield
- MNDR N/A
- PPBT N/A
- EPS Growth
- MNDR N/A
- PPBT N/A
- EPS
- MNDR N/A
- PPBT N/A
- Revenue
- MNDR $13,968,535.00
- PPBT N/A
- Revenue This Year
- MNDR $188,831.77
- PPBT N/A
- Revenue Next Year
- MNDR $76.44
- PPBT N/A
- P/E Ratio
- MNDR N/A
- PPBT N/A
- Revenue Growth
- MNDR 77.38
- PPBT N/A
- 52 Week Low
- MNDR $0.23
- PPBT $2.00
- 52 Week High
- MNDR $29.50
- PPBT $20.60
- Technical
- Relative Strength Index (RSI)
- MNDR N/A
- PPBT 38.31
- Support Level
- MNDR N/A
- PPBT $3.08
- Resistance Level
- MNDR N/A
- PPBT $3.33
- Average True Range (ATR)
- MNDR 0.00
- PPBT 0.25
- MACD
- MNDR 0.00
- PPBT -0.05
- Stochastic Oscillator
- MNDR 0.00
- PPBT 11.39
About MNDR Mobile-health Network Solutions Class A Ordinary Shares
Mobile-health Network Solutions is a company engaged in providing telehealth solutions in terms of various matrices, such as the number of patient consultations per day and the ranking of its mobile application. It provides services on its MaNaDr platform, which is accessible via mobile application and website. The MaNaDr platform is a platform designed and created by doctors, for doctors and users, equipped with services like consultations with doctors, e-commerce pharma store, and others. The company's operating segments are Telemedicine and other services which is also its key revenue generating segment, and Sale of medicine and medical devices. Geographically, it derives revenue from Singapore.
About PPBT Purple Biotech Ltd.
Purple Biotech Ltd is a clinical-stage company focused on advancing first-in-class therapies to overcome tumor immune evasion and drug resistance, and to create treatments for people with cancer. Its oncology pipeline includes NT219 and CM24.